StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $48.11B, up 9.7% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $48.11B in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.11B+9.7%
FY2024Dec 31, 2024$43.87B+16.8%
FY2023Dec 31, 2023$37.54B+17.5%
FY2022Dec 31, 2022$31.96B+27.9%
FY2021Dec 31, 2021$24.98B+17.2%
FY2020Dec 31, 2020$21.32B+9.5%
FY2019Dec 31, 2019$19.46B+13.5%
FY2018Dec 31, 2018$17.15B-5.5%
FY2017Dec 31, 2017$18.15B-3.9%
FY2016Dec 31, 2016$18.88B-5.9%
FY2015Dec 31, 2015$20.06B–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.86B+65.5%
Q2 FY2025Jun 30, 2025$11.98B+98.8%
Q2 FY2024Jun 30, 2024$10.76B+103.3%
Q2 FY2023Jun 30, 2023$9.46B+98.7%
Q2 FY2022Jun 30, 2022$7.77B+87.6%
Q2 FY2021Jun 30, 2021$6.03B+47.0%
Q2 FY2020Jun 30, 2020$5.29B–
Q2 FY2019Jun 30, 2019$4.76B–
Q2 FY2018Jun 30, 2018$4.14B–
Q2 FY2017Jun 30, 2017$4.10B–

More AstraZeneca figures

See a number that looks wrong?